Results 11 to 20 of about 447,008 (222)

Expression of CD56 (NKH-1) differentiation antigen in human thyroid epithelium

open access: yesClinical and Experimental Immunology, 1992
SUMMARYLeu-19 (CD56) MoAb is well known to recognize gp220 expressed on natural killer (NK) cells and is widely used as a NK cell marker. The expression of CD56 antigen was tested by means of sensitive alkaline phosphatase-anti-alkaline phosphatase (APAAP) immunohistochemical technique and the above mentioned MoAb as a primary antibody, on frozen ...
J, Zeromski   +3 more
openaire   +4 more sources

Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells [PDF]

open access: yesBMC Immunology, 2009
Background In lymphocyte subsets, expression of CD56 (neural cell adhesion molecule-1) correlates with cytotoxic effector activity. For cells bearing the Vγ2Vδ2 T cell receptor, isoprenoid pyrophosphate stimulation leads to uniform activation and ...
Focaccetti Chiara   +5 more
doaj   +2 more sources

Diagnostic confusion resulting from CD56 expression by cutaneous myeloid sarcoma

open access: yesRare Tumors, 2009
Myeloid sarcomas are tumor masses composed of aggregates of malignant myeloid precursors in extramedullary sites including the skin. We report a case of myeloid sarcoma in a patient who presented with an ear lobe mass and facial nerve paralysis ...
Sheeja T. Pullarkat   +3 more
doaj   +2 more sources

Prognostic value of B-cell maturation antigen, CD56 expression and neutrophil lymphocyte ratio in patients with multiple myeloma [PDF]

open access: yesActa Haematologica Polonica, 2022
Introduction: B-cell maturation antigen (BCMA) plays a critical role in regulating B-cell proliferation and differentiation into plasma cells. CD56 is involved in the adhesion of myeloma cells to the bone marrow matrix.
Mona Saied Fadilah   +4 more
openaire   +2 more sources

Characterisation of CD8neg and CD8+ human natural killer cell subsets [PDF]

open access: yes, 2012
NK cells are CD3neg CD56+ lymphocytes that constitute about 10-15% of peripheral blood lymphocytes. They have an innate ability to recognise and kill virus infected cells and tumour cells.
Abdalla, Ibrahim.I.I.
core   +6 more sources

The importance of CD7 and CD56 antigens in acute leukaemias

open access: yesInternational Journal of Clinical Practice, 2004
The prognostic significance of immunophenotypical properties of leukaemic cells is well known. However, the biological and clinical significance of CD7 and CD56 antigen expression in acute leukaemias are not clearly established. In patients with acute leukaemias, we identified CD7 and CD56 expression and analysed their associations with markers ...
N. Tiftik   +6 more
openaire   +3 more sources

Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization.

open access: yesFolia Histochemica et Cytobiologica, 2008
Evaluation of different types of lymphocyte subpopulations in the peripheral blood has unknown and controversial significance in diagnosis of infertility.
Rafał Kurzawa, Tomasz Baczkowski
doaj   +3 more sources

Localisation of the Ki-67 antigen within the nucleolus: Evidence for a fibrillarin-deficient region of the dense fibrillar component [PDF]

open access: yes, 1996
The Ki-67 antigen is detected in proliferating cells in all phases of the cell division cycle. Throughout most of interphase, the Ki-67 antigen is localised within the nucleolus.
Kill, IR
core   +6 more sources

Natural killer cell subset count and antigen‐stimulated activation in response to exhaustive running following adaptation to a ketogenic diet

open access: yesExperimental Physiology, 2023
We investigated the effect of a 31‐day ketogenic diet (KD) compared with a habitual, carbohydrate (CHO)‐based diet on total circulating natural killer (NK) CD3−CD56+, dim and bright subset count, and antigen‐stimulated CD3−CD56+ cell activation (CD69 ...
David M. Shaw   +3 more
doaj   +1 more source

IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study [PDF]

open access: yes, 2011
In an ongoing clinical phase I/II study, 16 pediatric patients suffering from high risk leukemia/tumors received highly purified donor natural killer (NK) cell immunotherapy (NK-DLI) at day (+3) +40 and +100 post haploidentical stem cell transplantation.
Claudia Brehm   +53 more
core   +1 more source

Home - About - Disclaimer - Privacy